Physician profile
Gail L Beaver
NPI 1689665887
$2,826.98
in general payments reported to CMS, 2019-2025
26 companies · $365 in 2025
The $365 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $617 · 2022: $704 · 2023: $545 · 2024: $596 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,505.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $396.55 | 2021-2025 | Mounjaro, Jardiance, Emgality |
| Abbvie INC. | $391.37 | 2021-2025 | |
| Novo Nordisk INC | $347.84 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $322.58 | 2021-2025 | Airsupra, Farxiga |
| Esperion Therapeutics, INC. | $220.93 | 2021-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $165.19 | 2022-2025 | |
| Amgen INC. | $130.46 | 2023-2025 | Repatha, Otezla, Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $77.46 | 2021-2024 | Trintellix |
| Amarin Pharma, INC. | $68.97 | 2021-2022 | |
| Pfizer INC. | $65.96 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $60.07 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $59.88 | 2024 | Sotyktu |
| Abbott Laboratories | $57.98 | 2021-2025 | Freestyle Libre 3 |
| Azurity Pharmaceuticals, INC. | $56.00 | 2023-2025 | Edarbi, Edarbi |
| Idorsia Pharmaceuticals US INC | $53.67 | 2023 | Quviviq |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $49.41 | 2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Tactile Systems Technology INC | $47.36 | 2023 | Entre Plus, Flexitouch Plus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.06 | 2022 | |
| Novartis Pharmaceuticals Corporation | $40.03 | 2022-2025 | |
| Eisai INC. | $36.82 | 2021 | |
| Clarus Therapeutics INC. | $34.69 | 2021 | |
| Lundbeck LLC | $30.28 | 2025 | Vyepti |
| Vanda Pharmaceuticals INC. | $24.58 | 2024 | Hetlioz, Fanapt |
| Medtronic, INC. | $18.72 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $14.22 | 2024 | Rexulti |
| Tolmar, INC. | $12.90 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gail Beaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.